Bleeding complications associated with glycoprotein IIb/IIIa inhibitors in patients 80 years of age and older undergoing percutaneous coronary intervention

BACKGROUND: Treatment of symptomatic coronary artery disease with percutaneous intervention requires antithrombotic therapy. Patients with elevated thromboembolic risk benefit from therapy with glycoprotein IIb/IIIa inhibitors. The safety and effectiveness of glycoprotein IIb/IIIa inhibition have be...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Germing, Alfried, Bojara, Waldemar, Lawo, Thomas, Ewers, Aydan, Grewe, Peter, Mügge, Andreas, Lindstaedt, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: Pulsus Group Inc 2010
Témata:
Clinical Cardiology: Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954030/
https://ncbi.nlm.nih.gov/pubmed/20959881
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky